In an interview with CNBC, J&J Chairman and CEO Alex Gorsky spoke about the partnership, calling it a "pivotal step" that could positively affect consumers and patients.
"If we can detect [AFib] earlier, we can get them the right medication [and] we can help them be compliant on these medications over a longer period of time. Ultimately, we're going to save lives," Mr. Gorsky said.
Mr. Gorsky said the partnership shows how technology is pushing its way further into healthcare.
"I think it really s…